Research of loss of heterozygaity on chromosome 3p in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 11, Issue 4, 2008, Pages 534-537

  Mei, Xinyu ^a   Sun, Yujie ^a   Xu, Meiqing ^a   Ma, Dongchun ^a   Wei, Dazhong ^a   Tian, Jieyong ^a   Ren, Zixue ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Loss of heterozygosity; Lung neoplasms; Nucleated cell

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CELL NUCLEUS; CHROMOSOME 3P; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 55549129282     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.04.017     Document Type: Article

References (11)

1. Ninomiya H, Nomura K, Satoh Y, et al. Genetic instability in lung cancer: concurrent, analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity. Br J Cancer, 2006, 94(10): 1485-1491.
2. Sean Todd, Wilbur A, Franklin, et al. Homozygous Deletions of Human Chromosome 3p in Lung Tumors. Cancer Res, 1997, 57(1): 1344-1352.
3. Wistuba II, Behrens C, Virmani AK, et al. High Resolution Chromosome 3p Allelotyping of Human Lung Cancer and Preneoplastic/Preinvasive Bronchial Epithelium Reveals Multiple, Discontinuous Sites of 3p Allele Loss and Three Regions of Frequent Breakpoints. Cancer Res, 2000, 60(7): 1949-1960.
4. Wali A, Srinivasan R, Shabnam MS, et al. Loss of Fragile Histidine Triad Gene Expression in Advanced Lung Cancer Is Consequent to Allelic Loss at 3p14 Locus and Promoter Methylation. Mol Cancer Res, 2006, 4(2): 93-99.
5. Ji L, Nishizaki M, Gao B, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res, 2002, 62(9): 2715-2720.
6. Zborovskaia IB, Tatosian AG. Molecular markers of various stages of nonsmall cell lung cancer development. Mol Biol (Mosk), 2004, 38(2): 191-202.
7. Sasatomi E, Finkelstein SD, Woods JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res, 2002, 62(9): 2681-2689.
8. Ito M, Ito G, Kondo M, et al. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Cancer Lett, 2005, 225(1): 131-139.
9. Wang XM, Peng QZ, Shan J, et al. Dependability of 3p loss of heterozygaity and NSCLC. Guangdong Med, 2007, 28(7): 1060-1062.
10. Guan SF, Xu KL, Zhao M, et al. Allele-specific chromosome 3p deletion in primary non-small cell lung cance. Chin J Lung Cancer, 2000, 3(1): 20-22.
11. Yoshino I, Osoegawa A, Yohena T, et al. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma. Respir Med, 2005, 99(3): 308-312.